Neurological adverse event profile of magnetic resonance imaging–guided focused ultrasound thalamotomy for essential tremor |
| |
| Authors: | Paul S. Fishman MD PhD W. Jeffrey Elias MD Pejman Ghanouni MD PhD Ryder Gwinn MD Nir Lipsman MD PhD Michael Schwartz MD Jin W. Chang MD PhD Takaomi Taira MD PhD Vibhor Krishna MD MSci Ali Rezai MD Kazumichi Yamada MD PhD Keiji Igase MD PhD Rees Cosgrove MD Haruhiko Kashima MD Michael G. Kaplitt MD PhD Travis S. Tierney MD PhD Howard M. Eisenberg MD |
| |
| Affiliation: | 1. University of Maryland School of Medicine, Baltimore, Maryland, USA;2. University of Virginia Health Sciences Center, Charlottesville, Virginia, USA;3. Stanford University School of Medicine, Stanford, California, USA;4. Swedish Neuroscience Institute, Seattle, Washington, USA;5. Sunnybrook Health Sciences Center, Toronto, Ontario, Canada;6. Yonsei University College of Medicine, Seoul, Korea;7. Tokyo Women's Medical University, Tokyo, Japan;8. Ohio State University Medical Center, Columbus, Ohio, USA;9. Kumamoto University Hospital, Kumamoto and Hokuto Hospital, Obihiro City, Japan;10. Washoukai Sadamoto Hospital, Matsuyama City, Japan;11. Brigham and Women's Hospital, Boston, Massachusetts, USA;12. Osaka University Hospital, Osaka, Japan;13. Weil Cornell School of Medicine, New York, New York, USA |
| |
| Abstract: | Background: Magnetic resonance imaging–guided focused ultrasound thalamotomy is approved by the U.S. Food and Drug Administration for treatment of essential tremor. Although this incisionless technology creates an ablative lesion, it potentially avoids serious complications of open stereotactic surgery. Objective: To determine the safety profile of magnetic resonance imaging–guided focused ultrasound unilateral thalamotomy for essential tremor, including frequency, and severity of adverse events, including serious adverse events. Methods: Analysis of safety data for magnetic resonance imaging–guided focused ultrasound thalamotomy (186 patients, five studies). Results: Procedure‐related serious adverse events were very infrequent (1.6%), without intracerebral hemorrhages or infections. Adverse events were usually transient and were commonly rated as mild (79%) and rarely severe (1%). As previously reported, abnormalities in sensation and balance were the commonest thalamotomy‐related adverse events. Conclusion: The overall safety profile of magnetic resonance imaging–guided focused ultrasound thalamotomy supports its role as a new option for patients with medically refractory essential tremor. © 2018 International Parkinson and Movement Disorder Society |
| |
| Keywords: | focused ultrasound MRgFUS essential tremor thalamotomy DBS |
|
|
